Chronic Kidney Disease Related Secondary Hyperparathyroidism

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2011-02-25
FDA Approved: SENSIPAR — Supplemental Application (Amgen Inc)
FDA approved Amgen's supplemental application for Sensipar (cinacalcet hydrochloride).